20.500.12556/DiRROS-29138 The role of ultra-rapid-acting insulin analogs in diabetes an expert consensus Ultra-rapid-acting insulin analogs (URAA) are a further development and refinement of rapid-acting insulin analogs. Because of their adapted formulation, URAA provide an even faster pharmacokinetics and thus an accelerated onset of insulin action than conventional rapid-acting insulin analogs, allowing for a more physiologic delivery of exogenously applied insulin. Clinical trials have confirmed the superiority of URAA in controlling postprandial glucose excursions, with a safety profile that is comparable to the rapid-acting insulins. Consequently, many individuals with diabetes mellitus may benefit from URAA in terms of prandial glycemic control. Unfortunately, there are only few available recommendations from authoritative sources for use of URAA in clinical practice. Therefore, this expert consensus report aims to define populations of people with diabetes mellitus for whom URAA may be beneficial and to provide health care professionals with concrete, practical recommendations on how best to use URAA in this context ultra-rapid-acting insulin URLi faster aspart insulin therapy type I diabetes type 2 diabetes true false true Angleški jezik Ni določen Neznano 2026-04-22 09:40:16 2026-04-22 09:40:16 2026-04-23 04:02:11 0000-00-00 00:00:00 2025 0 0 str. 452-469 iss. 2 Vol. 19 2025 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616.379 1932-3107 10.1177/19322968231204584 198982147 RAZ_Giorgino_Francesco_2025.pdf RAZ_Giorgino_Francesco_2025.pdf 1 E03DCD31E1C059A8376DA65488C1BE01 21af54d9fb35f6d9832e18f753af0e9a8dc28aedcc1d99cc4eb5ea382ab5ebed af09ac90-3e1e-11f1-a343-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=43539 https://journals.sagepub.com/doi/epub/10.1177/19322968231204584 1 8204f59f-3e1e-11f1-a343-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=43538 Univerzitetni klinični center Ljubljana 0 0 0